CAS No. |
79498-31-0 |
中文名称 |
(4aS,6R,6aR,9S,11aS,11bR,12R)-6,12-二羟基-4,4,11b-三甲基-8-亚甲基十二氢-6a,9-甲桥环庚并[a]萘-3,7-二酮 |
英文名称 |
(4aS,6R,6aR,9S,11aS,11bR,12R)-6,12-Dihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-3,7-dione |
别名 |
Wangzaozin B | CS-0018634 | Leukamenin F | 7alpha,14beta-dihydroxy-ent-kaur-16-ene-3,5-dione | HY-N2112 | Glaucocalyxin A | AC-34443 | MS-25010 | BDBM50552053 | (1R,2R,4S,9R,10S,13S,16R)-2,16-dihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.01,10 |
标准英文名 |
(4aS,6R,6aR,9S,11aS,11bR,12R)-6,12-dihydroxy-4,4,11b-trimethyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-3,7-dione |
分子式 |
C20H28O4 |
分子量 |
332.44
|
精确分子量 |
332.20
|
SMILES |
C=C1C(=O)[C@@]23[C@H](O)C[C@@H]4C(C)(C)C(=O)CC[C@@]4(C)[C@@H]2CC[C@@H]1[C@H]3O |
标准SMILES |
CC1(C)[C@H]2C[C@@H](O)[C@@]34[C@H](O)[C@@H](CC[C@H]3[C@]2(C)CCC1=O)C(=C)C4=O |
用途 |
Glaucocalyxin A exhibits anti-tumor activity by inhibiting proliferation of various human cancer cell lines (including CE-1, U87, A549, MCF-7, HeLa, K562, HepG2, NCI-H460, KB, JEG-3, HL-60, DU-145, and LoVo), suppressing growth of solid tumors (such as Lewis lung carcinoma, S180, and HCA), and prolonging survival in tumor-bearing mice; it induces apoptosis via the mitochondrial pathway and modulates the PI3K/Akt signaling pathway to inhibit GLI1 nuclear translocation; it also demonstrates anti-platelet aggregation effects, anti-bacterial activity, hepatoprotective properties, cardiovascular benefits, and immunosuppressive activity, showing therapeutic potential in autoimmune diseases such as systemic lupus erythematosus and psoriasis; additionally, it is used for content determination, compound identification, and pharmacological research. |
InChIKey |
UCDVIBNDYLUWFP-MJTHGBBVSA-N |